Company intelligence / Profile preview
Laboratorios Richmond
- Ownership
- Private
- Employees
- ~500
- Development stage
- Commercial
Overview
Laboratorios Richmond develops and manufactures a broad portfolio of generic pharmaceuticals and biosimilars. The company has commercialized antiretrovirals for HIV/AIDS as well as drugs for oncology/hematology and chronic diseases. It emphasizes access to affordable medicines through technology transfer partnerships with global firms. No specific clinical trial results are highlighted in public sources.
- Therapeutic areas
- OncologyCardiovascularNeurologyInfectious Diseases
- Modalities
- Small molecules (generic drugs)BiosimilarsFixed-dose combinations
- Industry
- Biotech
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →Partnerships
Beyond the preview
Go deeper on Laboratorios Richmond.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Laboratorios Richmond.